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Abstract
Background: Many young people with Attention Deficit Hyperactivity Disorder (ADHD) have impairing symptoms that
persist into adulthood, yet only a minority experience continuity of care into adult life. Despite growing emphasis on
the primary care role in ADHD management in NICE ADHD and transition guidance, little is known about GPs’
perspectives, which could hamper efforts to improve outcomes for young people leaving children’s services. This study
aimed to understand GPs’ experiences of involvement with this group and explore their views on the roles and
responsibilities of primary and secondary care in transition, to inform recommendations for policy and practice.
Method: Qualitative interview study with GPs across the UK. Semi-structured telephone interviews were carried out
with 14 GPs recruited through a linked mapping study, social media, and snowballing; data were analysed using
thematic analysis.
Results: In the absence of a smooth transition from child to adult services, many GPs became involved ‘by default’. GPs
reacted by trying to identify suitable specialist services, and were faced with the decision of whether to continue
ADHD prescribing. Such decisions were strongly influenced by perceptions that prescribing carried risks, and concerns
over responsibility, particularly where specialist services were lacking. Participants described variation in service
availability, and some highlighted tensions around how shared care works in practice.
Conclusion: Implementation of NICE guidance is highly variable, with implications for GPs and patients. Risk and
responsibility for primary care ADHD prescribing are central concerns that need to be addressed, as is the inclusion of
GPs in a planned transition process.
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Background
Up to 40% of young people with Attention Deficit
Hyperactivity Disorder (ADHD) will continue to experi-
ence impairing symptoms into adulthood [1]. Conse-
quently, a significant proportion of young people with
ADHD may benefit from continuing ADHD medication
into adult life. Based on recent surveillance of the need
for transition in the UK, a very conservative estimate of
the annual incidence of young people with an ongoing
need for medication for ADHD lies between 270 and
511 per 100,000 people aged 17–19 years [2]. Unplanned
cessation at this vulnerable stage can be detrimental [3–
5], and guidance from the National Institute for Health
and Care Excellence (NICE) now recommends that
young people should be reassessed at school-leaving age
to establish the need for continuing treatment, with ar-
rangements for a smooth transition to adult services
made if required [6].
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Much of the guidance around ADHD is aimed at sec-
ondary care services. However the updated guidelines on
ADHD stress the importance of the role of primary care,
which is mentioned as being ideally placed to provide
‘accessible’ monitoring and prescribing for people with
ADHD under shared care arrangements [6]. Guidance
on transition in general also recommends, that a named
worker should ‘proactively involve’ General Practitioners
(GPs) in the transition process, and that the GP should
also be included in annual meetings to review transition
planning [7]. More generally, the GP’s role as a universal
point of contact and a patient advocate can become even
more important once a young person leaves the familiar-
ity of children’s services [8], especially where the transi-
tion to an adult service for ADHD care is not initiated
or completed.
Provision of services for adults with ADHD remains
highly variable across the UK, and GPs have recently
warned that in some areas they are being pressured to
prescribe ADHD medication without specialist input,
contrary to guidance [9, 10] Similar concerns have been
voiced by patients on repeat prescriptions under the care
of their GP without specialist support [11]. However, lit-
tle is known from the research literature about the im-
pact of inconsistent specialist provision on GPs, or about
how they view their role in the care of young people
with ADHD in transition and beyond. A 2016 review of
GPs’ attitudes and knowledge found ‘mixed and scep-
tical’ views on the validity of the diagnosis, although the
included UK studies were over a decade old [12]. A
more recent study from Northern Ireland also
highlighted how concerns from GPs appeared to influ-
ence a low uptake of shared care partnerships for ADHD
prescribing in children [13].
Given an increasing emphasis on the primary care role
in monitoring and prescribing for adults with ADHD, a
lack of insight into the perspectives of GPs could ham-
per efforts to improve transition and optimise outcomes.
The aims of this qualitative study were to understand
GPs’ experiences of involvement with young people with
ADHD who require ongoing treatment into adulthood
and explore their views on the roles and responsibilities
of primary and secondary care in transition, in order to
inform recommendations for policy and practice.
Methods
This study formed part of the Children and Adolescents
with ADHD in Transition between Children’s and Adult
Service (CATCh-uS) research [14]. CATCh-uS was a
National Institute of Health Research (NIHR) funded
project which explored ADHD transition across the UK
through three research strands: [1] a surveillance study
of the incidence of transition [2] a mapping study to
identify and describe services for young adults with
ADHD, and [3] a qualitative study to explore key stake-
holder experience of transition from child to adult
services. This qualitative semi-structured interview study
formed part of the third strand.
Participants
We drew a convenience sample of GPs from across the
UK working in various practice types and regions from
respondents to the CATCh-uS online mapping survey
[14], advertisements on social media and the snowball
technique. Advertisements were also circulated via
NIHR Clinical Research Networks. GPs were asked to
complete an online form with their contact details to
indicate interest in participation.
Data collection
All participants provided written consent, including for
audio-recording of the interviews. Interviews took place
between October 2017 and November 2018, and were
carried out by telephone to be more flexible. A semi-
structured format was used (see Table 1 for areas cov-
ered). Interviews lasted on average 40min.
Data analysis
Interviews were transcribed verbatim and checked by
one of the research team. NVIVO software, version 12
[15], was used for data management. Thematic analysis
was used as it represents a clear and sequential method
for analysing qualitative interviews to describe partici-
pant experiences relating to a defined area [16]. Follow-
ing the first three interviews, the team undertook the
initial coding process, double coded initial interviews,
developed a coding frame and refined the topic guide
based on initial responses. Recruitment ceased once
there was consensus that there did not appear to be sig-
nificant new material emerging. Once all interviews were
coded by the team, the coding frame was revised and
used as the basis for discussions to build consensus on
the emerging themes and the model which links them
together. Throughout the process, attention was paid to
the differences in participants’ experiences and attitudes
and the identification of discrepant cases.
Table 1 Areas covered by the interview topic guide
▪ Experience of having young people in transition with ADHD on
caseload
▪ Involvement with transition, and presentation of young people with
ADHD to primary care
▪ Role in management of ADHD in transition and beyond
▪ Availability of adult mental health services, referral processes and
remit
▪ Support from secondary care, and shared care agreements
▪ Optimal management of transition
▪ Awareness of protocols and guidance
▪ The role of primary care in ADHD
▪ Views on training
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Research team
TND, AJ and JS (a male trainee psychiatrist) conducted
the interviews. For the analysis, TND and AJ were joined
by SB, all three of whom are experienced female qualita-
tive researchers and none of whom are in active clinical
practice. The different professional backgrounds of the
research team (psychiatry, public health, psychology,
anthropology, sociology and law) acted as a challenge to
any assumptions made in the analytical process.
Results
Of the 27 GPs that indicated interest on the online form,
interviews were carried out with 14; despite repeated at-
tempts to schedule an interview with the other 13 GPs,
we were unable to do so. The characteristics of partici-
pants are shown in Table 2. The career stage of the GPs
interviewed ranged from early career to nearing
retirement.
From our analysis of the interviews, the three main
themes that we developed were:
 Involvement ‘by default’
 Prescribing: pragmatic and pressured decisions, risk
and responsibility
 Working with secondary care
These themes are not necessarily chronologically or-
dered in the process of transition, and each may influ-
ence the other.
Involvement ‘by default’
A lack of communication and planning from secondary
care was a common feature. There was little evidence
from most interviews that GPs were alerted to the ap-
proaching transfer of care or involved in a planned tran-
sition process for young people under their care. Young
people were described as ‘turning up’ to the GP with no
plan in place and no information; “there’s sometimes an
unspoken assumption from community paediatrics that
we will just take over, and the young person or their par-
ents are told just go to your GP and get it. So communi-
cation sometimes has been very poor” (GP7). It was
apparent that often, the GP became involved and poten-
tially responsible ‘by default’, because a transition to an
adult service had not been initiated by child services or
was not successful, for various reasons. In some cases,
GP involvement came about as there was no adult ser-
vice for the young person to transition to: “As soon as
they hit adult, then there isn’t anyone who will actually
change their doses of medication to adult doses and it’s
just been put back on me” (GP13). In others, there may
have been an adult service, but care was not transferred
by the child services, possibly because there was an ex-
pectation that the GP would make the referral: “(Child
and Adolescent Mental Health Services (CAMHS)/
Paediatrics) send a letter saying the age is now out of
their hands. But they never actually transfer care to
adult ADHD services” (GP4).
Where no referral had been made by child services,
the GP themselves often sought access for their patient
to a specialist service: “when the young person comes to
us saying, ‘I haven’t been offered another appointment
because I’m not under that team anymore,’ then we have
to react to that and re-refer rather than secondary care
taking things into their own hands and doing it for us”
(GP3). ‘Trying’ was sometimes very much the operative
word: “We try and refer when they’re adults and then
they say there’s no service… so we would always try and
refer back even though we know that there’s no service…
or try and get them seen under a different service”
(GP12). A number of GPs then referred to the long wait
for adult services, which meant that, again, the GP was
involved ‘by default’, prescribing medication whilst the
young person waited to be seen: “So I sent a referral but
the referral takes ages…and I did feel kind of pressured
into prescribing the medication again… I felt quite un-
comfortable and pretty unsupported really” (GP11).
Prescribing: pragmatic and pressured decisions, risk and
responsibility
Finding themselves in a central role in transition ‘by
default’, often without being consulted or alerted by
child services, GPs sometimes felt pressurised to react,
with the situation triggering a defensive approach. “I
can’t remember why I was pressured into it…quite often,
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patients have very, very firm views about that kind of
thing” (GP11). Often the GP had to make a quick deci-
sion on whether or not they would prescribe medication
for the young adult given their specific situation, in the
absence of specialist guidance. It was clear that many
GPs felt they had to be pragmatic: “We have to treat
them regardless, that’s the problem with general practice”
(GP11). As part of this decision, they had to weigh up
the risks of prescribing against the risks of not prescrib-
ing, and their responsibility towards the patient: “when
you weigh up the risks and benefits of any said action,
probably the risks of stopping it are greater… (the risk)
that their mental health deteriorates and it’s all my
fault” (GP12). Their positions were influenced by various
factors including the availability and nature of secondary
care services, their beliefs about ADHD patients, ADHD
and ADHD medication.
The perception of risk was influenced by GPs’ views
on the qualities of the drugs, which were often seen as
being drugs of abuse: “it’s got potential side effects, it’s
addictive and it’s got street value as well” (GP7). Part of
the risk was also linked to these drugs being unfamiliar
and less frequently used in general practice, and hence
an area where expertise was limited: “They are relatively
specialised, relatively low numbers of patients and our
knowledge of that individual drug is going to be corres-
pondingly less” (GP6). ADHD patients were seen by one
GP as a ‘tricky’ group, with some having co-existing drug
and alcohol problems which contributed to the risk
involved in prescribing: “I feel these are tricky enough
patients as it is, to start getting into a battle…when
they’re going to say ‘But I need it, it helps me’” (GP11).
However, a minority of those interviewed felt that GPs
could ‘manage’, and did not share their colleagues’ con-
cerns about the nature of ADHD medication: “I think
with a bit of experience, I’m sure we could manage…be-
cause you’d just basically titrate it against the behav-
iour… It’s not actually a toxic drug as such” (GP8).
Where there was no formal agreement with secondary
care, most GPs felt that there were higher risks attached
to this prescribing: “there should be some sort of shared
care agreement…obviously we have legal responsibility as
the signatory on the script. So we are being used as a risk
sink in the name of saving money” (GP11). There were
also uncertainties and variation around what local pre-
scribing guidance and committees allowed: “there has
been a lot of confusion over whether we can prescribe or
not in adults’ transition” (GP7).
In one interview, a GP noted that some of their col-
leagues still ‘refused’ to prescribe despite the existence of
a shared care agreement in their CCG: “there are still
some rogue GPs, despite the shared care protocol being in
place and all signed off by the CCG, who still refuse to
prescribe” (GP5). Similarly, several GPs strongly felt that
prescribing ADHD medication was outside their remit
and should not be part of their role, even with additional
training: “I think the role of the GP should be managing
their primary health needs and not their mental health
needs…My personal view is that this is not my job. This
should be done by somebody else who knows about it.
Because they’re proper drugs” (GP12); “The assessment
and management of ADHD is in the specialist arena and
I am not sure that putting GPs through extra training on
ADHD would enhance the role that we take at the
moment” (GP3).
Concerns about the diagnosis itself were also promin-
ent, which influenced position on prescribing. Usually,
the GP was not involved either in the initial diagnosis of
ADHD or the decision to begin or continue prescribing,
and this could introduce discomfort: “it’s a controlled
medication and you are giving it on an ad hoc basis to
somebody that you weren’t involved in the decision to
give it to initially anyway” (GP3). The quality of the ini-
tial diagnosis was also sometimes questioned: “Some-
times we think well, actually, I don’t know on what basis
you ever really were prescribed these drugs, it’s not really
clear from your notes that you ever had a proper assess-
ment” (GP14). An even more pressing concern was
whether the young person still had ADHD: “I think that
an intrinsic problem is with adult ADHD trajectory,
which means that… we should all be worrying about
when we should be stopping the medication” (GP2).
Whilst there was acceptance from some GPs that ADHD
continued into adulthood: “it’s considered a childhood
problem but it obviously goes on forever in some form”
(GP8), from others there was a clear sense that there
were questions which the ‘experts’ needed to answer be-
fore the GP could act appropriately in terms of prescrib-
ing: “adolescent psychiatry should take some ownership
of that and decide whether it is something that’s legitim-
ately diagnosed or revisited in adulthood, or whether
adult psychiatry just disregards it… Has ADHD resolved?
Or does it not resolve? Should they be on treatment? …
It’s all just left to chance really” (GP11).
Working with secondary care
Most interviewees felt that what was on offer for young
people with ADHD was not meeting their needs: “Until
services are properly commissioned, I think there’s going
to be an unmet need there. It’s a real problem for pri-
mary care because they feel like they’re having to manage
things that they don’t necessarily feel comfortable with”
(GP13). Funding was repeatedly mentioned, but there
was also a feeling that adult ADHD was not a priority:
“But the NHS doesn’t have all the money in the world,
and in terms of disappointed people, because they’re not
being seen, the number in my experience is small…So I
get it, why there’s no service, but my interpretation or my
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experience of the problem is that it’s only a very small
problem in my practice population” (GP12).
It was clear from the interviews that there was consid-
erable variation in what was ‘on offer’ from adult sec-
ondary care. In some areas there appeared to be no
service at all that the GP was aware of; “Now, I had a
heck of a problem identifying a local service… no one in
the CCG (Clinical Commissioning Group) could identify
who was commissioned to do it” (GP10). Even where
there was some form of provision, the referral process
was not straightforward. For example, some GPs men-
tioned the separation of diagnosis and management in
adult services and one explained that although they
could refer to a national tertiary ADHD service, this re-
quired a special funding request and two referrals.
In some cases, secondary care arrangements were un-
clear, and roles and responsibilities undefined: “we will
continue to prescribe but we will ask them to review
when they can… it’s a bit vague” (GP1). In others, there
were formal shared care agreements about prescribing
and physical monitoring: “once they’ve been stabilised on
medication, we get a letter which is a shared care agree-
ment…they need to have… annual BMI and annual
pulse and blood pressure” (GP14). From several inter-
views, there was a sense that shared care protocols were
not necessarily clear or drawn up with the involvement
of primary care, leading to tensions: “it’s something that’s
been designed by secondary care and commissioners, not
actually the people who are expected to deliver the care”
(GP6); “It seems that the psychiatrist says I’ve done my
bit by putting a dense paragraph at the end full of all
this stuff that the GP is meant to do” (GP9).
Working with secondary care was positively influ-
enced by existing ‘informal’ relationships. For example,
some GPs had lines of communication with local spe-
cialists that meant they could seek advice without hav-
ing to go through a lengthy referral process: “they are a
virtual (service)… if there are concerns or questions then
they can be approached directly without having to go
through a referral process” (GP5). Such access to a spe-
cialist to ask questions (e.g. about dosage), was highly
valued, but often not available: “‘letter from secondary
care says: Please prescribe this. Re-refer back if there is
a problem’. No recognition of the fact that there’s
months and months’ worth of wait lists if you do actu-




This study aimed to understand GPs’ experiences of in-
volvement with young people with ADHD in transition,
and explore their views on the roles of primary and sec-
ondary care. We found that, often, in the absence of a
smooth transition from child to adult services, the GP
can become involved ‘by default’, instead of being
included in a planned process. GPs may then find them-
selves having to react to this situation, either by trying
to identify a specialist service for their patient, and/or
deciding on whether they will continue to prescribe
medication in these circumstances. Their decision mak-
ing process was strongly influenced by perceptions that
prescribing carried risks, leading to the question of
responsibility, particularly in the absence of access to
specialist care. This linked to our third theme, that of
variation in what was ‘on offer’ in their area in terms of
services, and also of the more informal working relation-
ships with secondary care and tensions around what was
formally commissioned or agreed.
Strengths and limitations
Our research is the first UK study to specifically examine
GP perspectives on transition in ADHD. Reflecting the
exploratory nature of this study, the sample size is small,
however it importantly provides insight into a range of
difficulties faced by GPs. While acutely aware of the
need to recruit GPs who represented the spectrum of
experience, role, and region, so few GPs responding to
the CATCh-uS online mapping survey consented to be
contacted that we were unable to create a large enough
sampling frame to purposively select participants accord-
ing to their characteristics. Our sample did include GPs
with different levels of experience, roles and practice
types, although the proportion of female GPs was lower
than the national average. We included a range of rural
and urban settings across the UK but were unable to
recruit GPs from every UK region. It is possible that the
GPs who did indicate interest were those experiencing
challenges with this patient group. However, our find-
ings also resonate with other literature in this area as
described below.
Comparison with existing literature
Our first theme of involvement ‘by default’ is echoed in
research exploring transition from the patient’s perspec-
tive, where young people also report being ‘dropped’ by
child services without a plan, and being told to go to
their GP [17]. Our findings around GPs’ perspectives on
ADHD and ADHD medication are also similar to previ-
ous research. The view from many of our participants
that ADHD drugs were ‘high risk’, with worries over ad-
diction, misuse and diversion, has been noted in other
studies and concern over longer-term effects of medica-
tion is also a familiar theme [18, 19]. Whilst NICE con-
clude in their latest guidance that medication for ADHD
“appears to be safe at least in the short term with very
few serious adverse events reported” [6]; the guidance
also acknowledges the need for professionals to be aware
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of the potential for diversion and misuse, as well as the
absence of good long term data on adverse effects.
Many of our participants were uncomfortable with the
prescribing role that they ended up in ‘by default’, and in
some cases this discomfort was present even where a
formal shared care arrangement was in place. Concerns
over shared care prescribing have also been evident in
other primary care research [13, 20]; Crowe et al.’s study
described challenges perceived by GPs in shared care for
specialist drugs in general, but also reported that such
arrangements with psychiatric drugs were considered
especially difficult due to ‘non-compliance’, mirroring
comments from our participants [20].
However, it seems there may have been some evo-
lution in how ADHD is viewed in primary care. The
‘negative and sceptical’ attitudes reported in Tatlow-
Golden’s 2016 review were perhaps less evident in
our study [12]; and a recent Irish survey of GPs also
found that a narrow majority reported ‘positive atti-
tudes’ [21]. For example, although we found some
concerns from participants about the legitimacy of
patients’ diagnoses, this appeared to stem more from
a desire for specialists to ‘reconfirm’ existing diagno-
ses at transition age (a NICE recommendation), a lack
of GP involvement in the initial diagnosis and treat-
ment process, and an absence of clear communication
and documentation, rather than disbelief about the
existence of the condition itself.
It is worth also noting that, whilst some participants
made a direct link between their lack of expertise and
unwillingness to prescribe, there was also a perception
from some GPs that this was more a matter of remit –
i.e. that ADHD was a specialist area where GPs should
have a limited role. This may be related to ‘pushback’
against a perceived shift in workload from secondary to
primary care, and the impact on primary care of raised
eligibility thresholds in mental health services [22, 23].
Finally, it is important to reflect that in our interviews
there appeared to be little room for discussion of a more
holistic approach to young people with ADHD in pri-
mary care, which might be considered to be more within
the GPs’ remit [8], given the more prominent and press-
ing concerns around prescribing.
Implications for research and practice
Our findings add to the evidence that what is happening
in practice for young people with ADHD who need con-
tinuing treatment bears little resemblance to the smooth
transition pathways recommended in the guidance [24–
26]. This study also supports the conclusion that current
service provision and practices (including the lack of fit
of ADHD as a condition with many AMHS structures)
may well be placing some GPs in the ‘invidious position’
described by Iacobucci [9], where their patients may go
without ADHD medication unless they prescribe outside
of shared care arrangements and counter to NICE guide-
lines. Future studies could build on the findings of this
research; for example case study approaches based on
different service models could further explore some of
these themes and identify contextual and cultural factors
which influence primary care ADHD management.
It seems likely that many of GPs’ concerns would be
alleviated by full implementation of the NICE guidance
on ADHD, including timely involvement of GPs in the
transition process, and the provision of services for
adults with ADHD across the country. An obvious bar-
rier to full implementation is the issue of resources. This
leads to a wider challenge about how to make the case
for commissioning further capacity in adult services in a
climate of limited resource and short-term planning,
where the benefits of services may accrue to different
sectors (e.g. the criminal justice system). In particular,
there is a need for evidence to support the economic
case for treating adult ADHD, and for a more coordi-
nated approach to evaluation of current transition and
adult ADHD models [24].
Linked to this, our research comes at a time where
there is debate about how adult ADHD care should be
organised, with discussions around the role of primary
care [8, 27, 28]. However, it is clear from our work that
many GPs perceive ADHD prescribing to be particularly
high risk and, in many cases, feel unsupported to man-
age this risk. There is an argument for GP training on
ADHD and medication licensing, in particular to address
specific concerns over the risks of prescribing ADHD
medication, how these compare to other medications,
and how they can be managed in partnership with spe-
cialists. That said, it is important to recognise that ‘train-
ing for GPs’ is not a magic bullet, and there are
demands for GPs to have further training and take on
expanded roles in various different conditions, hence en-
gagement and robust evaluation is required [29]. Our
findings emphasise that any proposed models for the
management of adult ADHD and transition of ADHD
patients from child to adult services should ensure that
workload and responsibility are safely and appropriately
allocated. In particular, our data should be seen in the
light of current pressures on GPs, and increasing expec-
tations of primary care [30]. More positively, there are
also a number of implications for practice which are less
dependent on resource. For example, improved commu-
nication between child services and primary care in
terms of transition would help to address the often un-
planned presentation of young people to their GP seek-
ing prescriptions. Similarly, confirmation of the ADHD
diagnosis and clear documentation of ongoing needs
prior to transition would also assist GPs in their decision
making and referrals. More transparent information for
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clinicians on what is ‘on offer’ locally for young people
with ADHD would assist all involved in the care of this
group to navigate through transition and beyond.
Finally, in terms of ‘economies of scale’, some of the
GPs we interviewed made the point that young adults
with ADHD represented only a small proportion of their
practice population. This is borne out by applying the
figures from the UK CATCh-uS surveillance study [2] to
Clinical Commissioning Group (responsible for commis-
sioning health services) and practice populations. For ex-
ample, for a Clinical Commissioning Group with a
population of 300,000 and more than 10,000 17–19 year
olds, this results in an estimate corresponding to 20–60
patients per year. For individual practices the number
would be likely to be small, with the average UK all-age
list size being approximately 7000 [31]. However, in
England there is increasing interest in the development
of primary care ‘at scale’, with practices joining together
in larger primary care networks with 30–50,000 patients
to pool expertise and resources [32]. Both these qualita-
tive findings and the surveillance estimates can therefore
contribute to important debates about how to organise
primary and secondary care services to meet the needs
of this group in a sustainable way.
Conclusions
Our study provides further evidence that the implemen-
tation of NICE guidelines for ADHD and transition is
highly variable, with implications both for GPs and for
patients. In a climate where primary care is under pres-
sure, it is crucial that frontline GPs are involved in ef-
forts to improve transition and develop sustainable
service models.
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